Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Findling

Showing results (221-230 of 443) with videos related to

Pageof 45
Sort By:
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|June 14, 2021
Developing Empirical Latent Profiles of Impulsive Aggression and Mood in Youths across Three Outpatient SamplesEric A Youngstrom, Andrea S Young, Katherine Van Eck, et al.
Bipolar Disorders|June 15, 2005
A US perspective of the CANMAT bipolar guidelinesJoseph R Calabrese, Paul E Keck, Charles L Bowden, et al.
Journal of Child and Adolescent Psychopharmacology|February 16, 2013
A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderRobert L Findling, Andrew J Cutler, Keith Saylor, et al.
Journal of Child and Adolescent Psychopharmacology|June 20, 2015
Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with SchizophreniaRobert L Findling, Ronald P Landbloom, Mary Mackle, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophreniaDavid E Kemp, Christoph U Correll, Mauricio Tohen, et al.
Journal of Child and Adolescent Psychopharmacology|November 2, 2011
Informant discrepancies in clinical reports of youths and interviewers' impressions of the reliability of informantsAndres De Los Reyes, Eric A Youngstrom, Anna J Swan, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 14, 2011
Internal consistency and associated characteristics of informant discrepancies in clinic referred youths age 11 to 17 yearsAndres De Los Reyes, Eric A Youngstrom, Shairy C Pabón, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 24, 2004
Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 yearsEric A Youngstrom, Robert L Findling, Joseph R Calabrese, et al.
Journal of Child and Adolescent Psychopharmacology|March 14, 2013
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorderEric Youngstrom, Joan Zhao, Raymond Mankoski, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorderRobert L Findling, Idil Cavuş, Elizabeth Pappadopulos, et al.
Pageof 45

Showing results (221-230 of 443) with videos related to

Sort By:
Pageof 45
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|June 14, 2021
Developing Empirical Latent Profiles of Impulsive Aggression and Mood in Youths across Three Outpatient SamplesEric A Youngstrom, Andrea S Young, Katherine Van Eck, et al.
Bipolar Disorders|June 15, 2005
A US perspective of the CANMAT bipolar guidelinesJoseph R Calabrese, Paul E Keck, Charles L Bowden, et al.
Journal of Child and Adolescent Psychopharmacology|February 16, 2013
A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderRobert L Findling, Andrew J Cutler, Keith Saylor, et al.
Journal of Child and Adolescent Psychopharmacology|June 20, 2015
Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with SchizophreniaRobert L Findling, Ronald P Landbloom, Mary Mackle, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophreniaDavid E Kemp, Christoph U Correll, Mauricio Tohen, et al.
Journal of Child and Adolescent Psychopharmacology|November 2, 2011
Informant discrepancies in clinical reports of youths and interviewers' impressions of the reliability of informantsAndres De Los Reyes, Eric A Youngstrom, Anna J Swan, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 14, 2011
Internal consistency and associated characteristics of informant discrepancies in clinic referred youths age 11 to 17 yearsAndres De Los Reyes, Eric A Youngstrom, Shairy C Pabón, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 24, 2004
Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 yearsEric A Youngstrom, Robert L Findling, Joseph R Calabrese, et al.
Journal of Child and Adolescent Psychopharmacology|March 14, 2013
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorderEric Youngstrom, Joan Zhao, Raymond Mankoski, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorderRobert L Findling, Idil Cavuş, Elizabeth Pappadopulos, et al.
Pageof 45